162 related articles for article (PubMed ID: 22716135)
1. Treatment of cannabis use among people with psychotic disorders: a critical review of randomised controlled trials.
Baker AL; Thornton LK; Hides L; Dunlop A
Curr Pharm Des; 2012; 18(32):4923-37. PubMed ID: 22716135
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.
Baker AL; Hides L; Lubman DI
J Clin Psychiatry; 2010 Mar; 71(3):247-54. PubMed ID: 20331929
[TBL] [Abstract][Full Text] [Related]
3. Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report.
Cooper K; Chatters R; Kaltenthaler E; Wong R
Health Technol Assess; 2015 Jul; 19(56):1-130. PubMed ID: 26202542
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatment for psychotic depression.
Wijkstra J; Lijmer J; Balk F; Geddes J; Nolen WA
Cochrane Database Syst Rev; 2005 Oct; (4):CD004044. PubMed ID: 16235348
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review.
Wilson RP; Bhattacharyya S
J Psychopharmacol; 2016 Feb; 30(2):99-111. PubMed ID: 26510450
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cannabis use disorders in people with schizophrenia spectrum disorders - a systematic review.
Hjorthøj C; Fohlmann A; Nordentoft M
Addict Behav; 2009; 34(6-7):520-5. PubMed ID: 19268481
[TBL] [Abstract][Full Text] [Related]
7. Cannabis Use Among Patients With Psychotic Disorders.
Hirschtritt ME; Young-Wolff KC; Mathalon DH; Satre DD
Perm J; 2021 May; 25():. PubMed ID: 35348056
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review.
Reid S; Bhattacharyya S
Psychiatry Res; 2019 Oct; 280():112523. PubMed ID: 31450032
[TBL] [Abstract][Full Text] [Related]
9. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
10. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
11. Measuring individual benefits of psychiatric treatment using longitudinal binary outcomes: Application to antipsychotic benefits in non-cannabis and cannabis users.
Zhang X; de Leon J; Crespo-Facorro B; Diaz FJ
J Biopharm Stat; 2020 Sep; 30(5):916-940. PubMed ID: 32511941
[TBL] [Abstract][Full Text] [Related]
12. The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.
Hahn B
Schizophr Bull; 2018 Jan; 44(1):46-53. PubMed ID: 29083450
[TBL] [Abstract][Full Text] [Related]
13. Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report.
Tucker MG; Kekulawala S; Kent M; Mostafa S; Harvey R
J Med Case Rep; 2016 Sep; 10(1):242. PubMed ID: 27599617
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for cannabis dependence: how close are we?
Vandrey R; Haney M
CNS Drugs; 2009; 23(7):543-53. PubMed ID: 19552483
[TBL] [Abstract][Full Text] [Related]
15. Medicinal cannabis (Bedrolite) substitution therapy in inpatients with a psychotic disorder and a comorbid cannabis use disorder: A case series.
Schipper R; Dekker M; de Haan L; van den Brink W
J Psychopharmacol; 2018 Mar; 32(3):353-356. PubMed ID: 29039260
[TBL] [Abstract][Full Text] [Related]
16. Clotiapine for acute psychotic illnesses.
Carpenter S; Berk M
Cochrane Database Syst Rev; 2001; (1):CD002304. PubMed ID: 11279762
[TBL] [Abstract][Full Text] [Related]
17. Anxiety mediates the association between cannabis use and attenuated positive psychotic symptoms.
Reeves LE; Anglin DM; Heimberg RG; Gibson LE; Fineberg AM; Maxwell SD; Kerns CM; Ellman LM
Psychiatry Res; 2014 Aug; 218(1-2):180-6. PubMed ID: 24745470
[TBL] [Abstract][Full Text] [Related]
18. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore TH; Zammit S; Lingford-Hughes A; Barnes TR; Jones PB; Burke M; Lewis G
Lancet; 2007 Jul; 370(9584):319-28. PubMed ID: 17662880
[TBL] [Abstract][Full Text] [Related]
19. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.
Hides L; Dawe S; Kavanagh DJ; Young RM
Br J Psychiatry; 2006 Aug; 189():137-43. PubMed ID: 16880483
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
